Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-047221
Filing Date
2025-03-05
Accepted
2025-03-05 16:28:14
Documents
5
Effectiveness Date
2025-03-05

Document Format Files

Seq Description Document Type Size
1 S-8 d824752ds8.htm S-8 34862
2 EX-5.1 d824752dex51.htm EX-5.1 6543
3 EX-23.1 d824752dex231.htm EX-23.1 1435
4 EX-FILING FEES d824752dexfilingfees.htm EX-FILING FEES 22393
5 GRAPHIC g824752g0304084905406.jpg GRAPHIC 2612
  Complete submission text file 0001193125-25-047221.txt   70023
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285571 | Film No.: 25711574
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)